Kingfa Science & Technology (India) Limited
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India. It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and L… Read more
Kingfa Science & Technology (India) Limited (KINGFA) - Total Liabilities
Latest total liabilities as of September 2025: ₹4.40 Billion INR
Based on the latest financial reports, Kingfa Science & Technology (India) Limited (KINGFA) has total liabilities worth ₹4.40 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Kingfa Science & Technology (India) Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Kingfa Science & Technology (India) Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Kingfa Science & Technology (India) Limited Competitors by Total Liabilities
The table below lists competitors of Kingfa Science & Technology (India) Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shimao Services Holdings Limited
PINK:SHMSF
|
USA | $5.44 Billion |
|
China Lilang Limited
F:5LX
|
Germany | €2.43 Billion |
|
CJ Freshway Corporation
KQ:051500
|
Korea | ₩1.16 Trillion |
|
Boyaa Interactive International Limited
F:1BY
|
Germany | €562.55 Million |
|
CARYSIL LIMITED
NSE:CARYSIL
|
India | ₹4.74 Billion |
|
Sinotherapeutics Inc. A
SHG:688247
|
China | CN¥142.10 Million |
|
Daesang Holdings Co Ltd Pref
KO:084695
|
Korea | ₩2.74 Trillion |
|
HLSCF
PINK:HLSCF
|
USA | $4.20 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Kingfa Science & Technology (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.52 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kingfa Science & Technology (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kingfa Science & Technology (India) Limited (2006–2025)
The table below shows the annual total liabilities of Kingfa Science & Technology (India) Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹4.26 Billion | +4.94% |
| 2024-03-31 | ₹4.06 Billion | -25.44% |
| 2023-03-31 | ₹5.44 Billion | +10.62% |
| 2022-03-31 | ₹4.92 Billion | +55.20% |
| 2021-03-31 | ₹3.17 Billion | +28.00% |
| 2020-03-31 | ₹2.48 Billion | +9.17% |
| 2019-03-31 | ₹2.27 Billion | +28.87% |
| 2018-03-31 | ₹1.76 Billion | -35.30% |
| 2017-03-31 | ₹2.72 Billion | +145.53% |
| 2016-03-31 | ₹1.11 Billion | -1.17% |
| 2015-03-31 | ₹1.12 Billion | +23.45% |
| 2014-03-31 | ₹908.42 Million | +40.04% |
| 2013-03-31 | ₹648.70 Million | +2.76% |
| 2012-03-31 | ₹631.26 Million | -8.93% |
| 2011-03-31 | ₹693.17 Million | +29.04% |
| 2010-03-31 | ₹537.18 Million | +1.47% |
| 2009-03-31 | ₹529.40 Million | -0.28% |
| 2008-03-31 | ₹530.90 Million | +38.39% |
| 2007-03-31 | ₹383.62 Million | +7.16% |
| 2006-03-31 | ₹358.01 Million | -- |